Journal
VIROLOGICA SINICA
Volume 36, Issue 6, Pages 1465-1474Publisher
KEAI PUBLISHING LTD
DOI: 10.1007/s12250-021-00438-z
Keywords
Chikungunya virus (CHIKV); Alphavirus; Lycorine; Antiviral
Categories
Funding
- National Key Research and Development Program of China [2018YFA0507201]
Ask authors/readers for more resources
Lycorine can inhibit CHIKV in cell culture without cytotoxicity and exhibits broad-spectrum anti-alphavirus activity at an early post-entry stage of CHIKV life cycle.
Chikungunya virus (CHIKV) is a mosquito-borne alphavirus. As an emerging virus, CHIKV imposes a threat to public health. Currently, there are no vaccines or antivirals available for the prevention of CHIKV infection. Lycorine, an alkaloid from Amaryllidaceae plants, has antiviral activity against a number of viruses such as coronavirus, flavivirus and enterovirus. In this study, we found that lycorine could inhibit CHIKV in cell culture at a concentration of 10 mu mol/L without apparent cytotoxicity. In addition, it exhibited broad-spectrum anti-alphavirus activity, including Sindbis virus (SINV), Semliki Forest virus (SFV), and Venezuelan equine encephalomyelitis virus (VEEV). The time of addition studies indicated that lycorine functions at an early post-entry stage of CHIKV life cycle. The results based on two different CHIKV replicons provided further evidence that lycorine exerts its antiviral activity mainly by inhibiting CHIKV translation. Overall, our study extends the antiviral spectrum of lycorine.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available